AR059353A1 - DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES. - Google Patents
DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES.Info
- Publication number
- AR059353A1 AR059353A1 ARP070100507A AR059353A1 AR 059353 A1 AR059353 A1 AR 059353A1 AR P070100507 A ARP070100507 A AR P070100507A AR 059353 A1 AR059353 A1 AR 059353A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- aryl
- group
- nr9r10
- heteroaryl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Los compuestos en el tratamiento de enfermedades donde está implicada una activacion de los receptores M3, tales como las enfermedades del tracto respiratorio. Reivindicacion 1: Un compuesto de formula (1); en la cual (i) R1 es alquilo C1-6 o hidrogeno; y R2 es hidrogeno o un grupo R7, -Z-Y-R7, -Z-NR9R10; -Z-CO-NR9R10, -Z-NR9-C(O)O-R7, o -Z-C(O)-R7; y R3 es un par solitario o alquilo C1-6, o (ii) R1 y R3 junto con el nitrogeno al cual están unidos forman un anillo de heterocicloalquilo, y R2 es un par solitario o un grupo -R7, -Z-Y-R7, -Z-NR9R10, -Z-CO-NR9R10, -Z-NR9-C(O)O-R7 o -Z-C(O)-R7; o (iii) R1 y R2 junto con el nitrogeno al cual están unidos forman un anillo de heterocicloalquilo, y dicho anillo está substituido por un grupo -Y-R7, -Z-Y-R7, Z-NR9R10, -Z-CO-NR9R10; -Z-NR9-C(O)O-R7 o -Z-C(O)-R7; y R3 es un par solitario o alquilo C1-6; y R4 y R5 se seleccionan independientemente entre el grupo que comprende arilo, heterocicloalquilo fusionado o arilo, heteroarilo, alquilo C1-6, cicloalquilo; R6 es -OH, halogeno, alquilo C1-6, alcoxi C1-6, hidroxi-alquilo C1-6, nitrilo, un grupo CONR82 o un H; A es O o S; X es alquinileno, alquenileno o alquinileno; R7 es un grupo alquilo C1-6, arilo, cicloalquilo fusionado a arilo, heterocicloalquilo fusionado a arilo, heteroarilo, aril (alquiloC1-8)-, heteroaril (alquiloC1-8)-, cicloalquilo o heterocicloalquilo; R8 es alquilo C1-6 o un átomo de hidrogeno; Z es un grupo alquileno C1-16, alquenileno C2-16 o alquinileno C2-16; Y es un enlace o átomo de hidrogeno; R9 y R10 son independientemente un átomo de H, alquilo C1-6, arilo, heterocicloalquilo fusionado a arilo, cicloalquilo fusionado a arilo, heteroarilo, aril (alquilo C1-6) o heteroaril (alquilo C1-6)-; o R9 y R10 junto con el átomo de nitrogeno al cual están unidos forman un anillo heterocíclico de 4-8 átomos, que opcionalmente contiene otro átomo de nitrogeno u oxígeno; o su sal farmacéuticamente aceptable, solvato, N-oxido o profármaco.Compounds in the treatment of diseases where an activation of M3 receptors is involved, such as respiratory tract diseases. Claim 1: A compound of formula (1); in which (i) R 1 is C 1-6 alkyl or hydrogen; and R2 is hydrogen or a group R7, -Z-Y-R7, -Z-NR9R10; -Z-CO-NR9R10, -Z-NR9-C (O) O-R7, or -Z-C (O) -R7; and R3 is a solitary pair or C1-6 alkyl, or (ii) R1 and R3 together with the nitrogen to which they are attached form a heterocycloalkyl ring, and R2 is a solitary pair or a group -R7, -ZY-R7, -Z-NR9R10, -Z-CO-NR9R10, -Z-NR9-C (O) O-R7 or -ZC (O) -R7; or (iii) R1 and R2 together with the nitrogen to which they are attached form a heterocycloalkyl ring, and said ring is substituted by a group -Y-R7, -Z-Y-R7, Z-NR9R10, -Z-CO-NR9R10; -Z-NR9-C (O) O-R7 or -Z-C (O) -R7; and R3 is a solitary pair or C1-6 alkyl; and R4 and R5 are independently selected from the group comprising aryl, fused heterocycloalkyl or aryl, heteroaryl, C1-6 alkyl, cycloalkyl; R6 is -OH, halogen, C1-6 alkyl, C1-6 alkoxy, hydroxy-C1-6 alkyl, nitrile, a CONR82 group or an H; A is O or S; X is alkynylene, alkenylene or alkynylene; R7 is a C1-6 alkyl, aryl, aryl fused cycloalkyl, aryl fused heterocycloalkyl, heteroaryl, aryl (C1-8 alkyl) -, heteroaryl (C1-8 alkyl) -, cycloalkyl or heterocycloalkyl group; R8 is C1-6 alkyl or a hydrogen atom; Z is a C1-16 alkylene, C2-16 alkenylene or C2-16 alkynylene group; And it is a hydrogen bond or atom; R9 and R10 are independently an atom of H, C1-6 alkyl, aryl, aryl fused heterocycloalkyl, aryl fused cycloalkyl, heteroaryl, aryl (C1-6 alkyl) or heteroaryl (C1-6 alkyl) -; or R9 and R10 together with the nitrogen atom to which they are attached form a heterocyclic ring of 4-8 atoms, which optionally contains another nitrogen or oxygen atom; or its pharmaceutically acceptable salt, solvate, N-oxide or prodrug.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP070100507 AR059353A1 (en) | 2007-02-07 | 2007-02-07 | DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP070100507 AR059353A1 (en) | 2007-02-07 | 2007-02-07 | DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR059353A1 true AR059353A1 (en) | 2008-03-26 |
Family
ID=39272771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070100507 AR059353A1 (en) | 2007-02-07 | 2007-02-07 | DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES. |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR059353A1 (en) |
-
2007
- 2007-02-07 AR ARP070100507 patent/AR059353A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR046297A1 (en) | DPP INHIBITORS - IV METHODS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE AGENTS | |
AR047098A1 (en) | ARILANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEIVER AGONISTS | |
AR083849A1 (en) | ESPIRO-OXINDOL MDM2 ANTAGONISTS | |
AR044874A1 (en) | DERIVATIVES OF 4- CIANOPIRAZOL-3 - CARBOXAMIDE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
AR083070A1 (en) | ANALOGS OF NUCLEOTID REPLACED WITH NITROGEN HETEROCICLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME TO TREAT VIRAL DISEASES, IN PARTICULAR HCV INFECTIONS | |
JP2008526999A5 (en) | ||
CL2009000127A1 (en) | [Indole, azaindole] -2-carboxamide derivative compounds substituted with a silanyl group; preparation procedure; intermediate compounds; pharmaceutical composition; and its use in the treatment of pain, inflammation, metabolic disorders, among other diseases mediated by modulation of the trpv1 receptor. | |
AR049464A1 (en) | ANTAGONISTS OF MUSCARINIC ACETILCOLINE RECEPTORS. PHARMACEUTICAL COMPOSITIONS | |
AR058073A1 (en) | IMIDAZOL 5-IL-PYRIMIDINE DERIVATIVES, OBTAINING PROCESSES, PHARMACEUTICAL COMPOSITIONS AND USES | |
CO5700720A2 (en) | DERIVATIVES OF N- (QUINOLIN-5L) ALQUILAMIDA-REPLACED; N-ALQUILQUINOLIN-5-CARBOXAMIDA-REPLACED; N-ALQUILISOQUINOLIN-5-CARBOXAMIDA-SUBSTITUTED; N- (ISOQUINOLIN-5-YL) ALQUILAMIDA-REPLACED AND PROCESSES FOR PREPARATION | |
AR035617A1 (en) | COMPOUNDS DERIVED FROM PHENETHANOLAMINE, COMBINATIONS AND PHARMACEUTICAL FORMULATIONS OF THE SAME, PROCESS FOR THEIR PREPARATION, ITS USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OR PROPHYLAXIS OF A CLINICAL CONDITION FOR WHICH A BETAIEPAR BARDIAR AGENT IS ADDED | |
PE20151602A1 (en) | SALTS OF DERIVATIVES OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2 (1H) -ONE THAT HAVE AGONISTIC ACTIVITY OF THE B (beta) 2 ADRENERGIC RECEPTOR AS WELL AS ANTAGONIST ACTIVITY OF THE MUSCARINIC RECEPTOR M3 | |
AR083069A1 (en) | ANALOGS OF SUBSTITUTED NUCLEOTIDES | |
AR082994A1 (en) | PYRAZINE DERIVATIVES AS BLOCKERS OF THE SODIUM EPITELIAL CHANNEL | |
AR064253A1 (en) | BICYCLOCARBOXYAMIDE COMPOUNDS REPLACED PHARMACEUTICAL COMPOSITIONS AND A COMBINATION THAT INCLUDES THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY THE RECEIVER'S ACTIVITY VR1 | |
HRP20080052T3 (en) | Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation | |
AR052938A1 (en) | N-SULFONYLAMINOFENILETIL-2-PHENOXYACETAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY RECEIVER VR1 | |
AR069490A1 (en) | GLUCOCORTICOID RECEPTORS AGONISTS | |
AR054272A1 (en) | DERIVATIVES OF 3- AMINOPIRRILIDINAS TRI, TETRA - SUBSTITUTED | |
AR087915A1 (en) | N- (3- (2-AMINO-6,6-DIFLUOR-4,4A, 5,6,7,7A-HEXAHYDRO-CYCLOPENTA- [E] [1,3] OXAZIN-4-IL) -PENYL) - AMIDAS AS INHIBITORS OF THE BACE1 | |
AR059328A1 (en) | DERIVATIVES OF ANTRANILAMIDA-2-AMINO-HETEROARENO-CARBOXAMIDA, A PROCESS FOR THEIR OBTAINING, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF THESE COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CETP MEDIATION | |
PE20081227A1 (en) | INDAZOLYL SULPHONAMID DERIVATIVES AS MODULATORS OF GLUCOCORTICOIDES | |
AR060604A1 (en) | NEW ARILAMINO N- HETEROARILOS AS MEK INHIBITORS | |
AR067412A1 (en) | PHARMACEUTICAL PROPERTY MODULATORS OF THERAPEUTIC PRODUCTS | |
AR063275A1 (en) | CARBOXAMIDE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY THE ACTIVATION OF CCR2. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |